Episode Details

Back to Episodes
What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

Season 23 Episode 26 Published 2 years, 3 months ago
Description

Prof Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma, moderated by Dr Neil Love.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us